HFB200301

· HiFiBiO Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HFB200301, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors [Phase 1]

See pricing